Stryker (NYSE:SYK) shares dipped after hours today despite second-quarter results that topped the consensus forecast. The Kalamazoo, Mich.-based company posted profits of $592 million, or $1.55 per share, on sales of $4.3 billion for the three months ended June 30, 2021, marking a massive bottom-line gain from losses of $83 million this time last year […]
Featured
NeuroMetrix stock slides on publication of Quell study
NeuroMetrix (NSDQ:NURO) stock is hitting a massive skid this week after the publication of a study on its Quell non-invasive nerve stimulation device for pain relief. Shares of NURO were down -12.2% at $18.41 apiece by late-afternoon trading yesterday on the news. The stock continues to decline today, down –7.1% to $16.94 per share by […]
AliveCor, Acutus partner on remote monitoring pilot study
AliveCor and Acutus Medical (NSDQ:AFIB) today announced a collaboration to study the integration of data collection tools in cardiology. The companies plan to launch a post-market U.S. pilot study in the third quarter of 2021 to gain insights on how physicians can use AliveCor’s KardiaMobile electrocardiogram (ECG) device to facilitate pre-ablation and/or post-ablation remote monitoring […]
GE beats The Street as healthcare segment thrives in Q2
GE (NYSE:GE) shares ticked up today on second-quarter results that beat the consensus forecast. The Boston-based company’s healthcare segment posted profits of $801 million, registering a bottom-line gain of 58.3% year-over-year on sales of $4.5 billion — a 14% increase on revenues from the previous year. GE’s overall sales totaled $18.3 billion for the three […]
3M’s healthcare segment registers growth in Street-beating Q2
3M (NYSE:MMM) reported second-quarter results that beat the consensus forecast — with the company’s healthcare segment showing especially robust growth. The St. Paul, Minn.–based company posted profits of $1.5 billion, or $2.59 per share, on sales of $9 billion for the three months ended June 30, 2021, for a 16.7% bottom-line gain on sales growth […]
BD acquires resorbable polymer maker Tepha
BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed amount. Franklin Lakes, N.J.–based BD said that it will use Tepha’s resorbable polymer technology to accelerate growth of the company’s surgical mesh for soft tissue repair, reconstruction and regeneration. Tepha’s GalaFlex portfolio is also included in the acquisition. “This strategic […]
Boston Scientific rises on Street-beating Q2
Boston Scientific (NYSE:BSX) shares are up today on second-quarter results that topped the consensus forecast. The Marlborough, Mass.-based company posted profits of $172 million, or 12¢ per share, on sales of $3.1 billion for the three months ended June 30, 2021, marking a massive bottom-line gain from losses of $153 million this time last year. […]
PerkinElmer announces Street-beating Q2, plans to acquire BioLegend for $5.3B
PerkinElmer (NYSE:PKI) today posted Street-beating second-quarter revenues and announced the $5.3 billion acquisition of BioLegend. The Waltham, Mass.-based company posted profits of $245.9 million, or $2.19 per share, on sales of $1.2 billion for the three months ended July 4, 2021, for a 79.3% bottom-line gain on sales growth of 51.3%. Adjusted to exclude one-time […]
MedTech 100 roundup: Return to normal after last week’s spike
After rising more than 31 points to heights never before reached, the medtech industry returned to normal this past week. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 23) at 115.54 points, a total that, had it not been for the previous week, would […]
How COVID-19 changed medical device clinical trials forever
The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on […]
Pfizer-BioNTech to provide U.S. with another 200M shots for kids, boosters
Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that the U.S. government has purchased another 200 million doses of their COVID-19 vaccine. Media outlets including CNN and the Financial Times cited a Biden administration official saying the additional doses are needed to vaccinate children under 12, pending FDA authorization, plus the potential need for additional booster shots against variants. In […]
